Innovent Announced 2022 Interim Results and Business Updates
- Written by PR Newswire
- Leading the Way in Developing a More Sustainable Business Model for Innovative Biopharmaceutical Companies
- Commercial Model and Platform Upgraded to Stage 2.0
- A Robust Pipeline of 34 Valuable Assets Supporting Continuously Growth Momentum
ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX:...
Read more: Innovent Announced 2022 Interim Results and Business Updates














